The movement disorder society - 14th international congress of Parkinson's disease and movement disorders

Grosset, D. and Grosset, A. (2010) The movement disorder society - 14th international congress of Parkinson's disease and movement disorders. IDrugs, 13(8), 539--542. (PMID:20721824)

Full text not currently available from Enlighten.

Abstract

The 14th International Congress of Parkinson's Disease and Movement Disorders, held in Buenos Aires, included topics covering new therapeutic developments in the field of Parkinson's disease and other movement disorders. This conference report highlights selected presentations on drug treatments for movement disorders, including safinamide (Merck Serono SA), PYM-50028 (Phytopharm plc), droxidopa, pardoprunox (Abbott Laboratories); treatment considerations for dystonia; exploiting existing drugs for new indications; and using genetics to assess drug therapy responses.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Grosset, Dr Donald
Authors: Grosset, D., and Grosset, A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Neuroscience and Psychology
Journal Name:IDrugs
Publisher:Thomson Scientific
ISSN:1369-7056
ISSN (Online):2040-3410
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record